Identification of rifampin-regulated functional modules and related microRNAs in human hepatocytes based on the protein interaction network
Open Access
- 22 August 2016
- journal article
- research article
- Published by Springer Nature in BMC Genomics
- Vol. 17 (S7) , 517
Abstract
In combination with gene expression profiles, the protein interaction network (PIN) constructs a dynamic network that includes multiple functional modules. Previous studies have demonstrated that rifampin can influence drug metabolism by regulating drug-metabolizing enzymes, transporters, and microRNAs (miRNAs). Rifampin induces gene expression, at least in part, by activating the pregnane X receptor (PXR), which induces gene expression; however, the impact of rifampin on global gene regulation has not been examined under the molecular network frameworks. In this study, we extracted rifampin-induced significant differentially expressed genes (SDG) based on the gene expression profile. By integrating the SDG and human protein interaction network (HPIN), we constructed the rifampin-regulated protein interaction network (RrPIN). Based on gene expression measurements, we extracted a subnetwork that showed enriched changes in molecular activity. Using the Kyoto Encyclopedia of Genes and Genomes (KEGG), we identified the crucial rifampin-regulated biological pathways and associated genes. In addition, genes targeted by miRNAs that were significantly differentially expressed in the miRNA expression profile were extracted based on the miRNA-gene prediction tools. The miRNA-regulated PIN was further constructed using associated genes and miRNAs. For each miRNA, we further evaluated the potential impact by the gene interaction network using pathway analysis. We extracted the functional modules, which included 84 genes and 89 interactions, from the RrPIN, and identified 19 key rifampin-response genes that are associated with seven function pathways that include drug response and metabolism, and cancer pathways; many of the pathways were supported by previous studies. In addition, we identified that a set of 6 genes (CAV1, CREBBP, SMAD3, TRAF2, KBKG, and THBS1) functioning as gene hubs in the subnetworks that are regulated by rifampin. It is also suggested that 12 differentially expressed miRNAs were associated with 6 biological pathways. Our results suggest that rifampin contributes to changes in the expression of genes by regulating key molecules in the protein interaction networks. This study offers valuable insights into rifampin-induced biological mechanisms at the level of miRNAs, genes and proteins.Keywords
This publication has 43 references indexed in Scilit:
- Population pharmacokinetics of rifampin in the treatment of Mycobacterium tuberculosis in Asian elephantsJournal of Veterinary Pharmacology and Therapeutics, 2014
- Integrated Analysis of Rifampicin-induced MicroRNA and Gene Expression Changes in Human HepatocytesDrug Metabolism and Pharmacokinetics, 2014
- Regulation of MicroRNA Expression by Rifampin in Human HepatocytesDrug Metabolism and Disposition, 2013
- Global Metabolomics and Targeted Steroid Profiling Reveal That Rifampin, a Strong Human PXR Activator, Alters Endogenous Urinary Steroid MarkersJournal of Proteome Research, 2013
- Crosstalk between transcription factors and microRNAs in human protein interaction networkBMC Systems Biology, 2012
- Identification of microRNA-regulated gene networks by expression analysis of target genesGenome Research, 2012
- Fucoxanthin Attenuates Rifampin-Induced Cytochrome P450 3A4 (CYP3A4) and Multiple Drug Resistance 1 (MDR1) Gene Expression Through Pregnane X Receptor (PXR)-Mediated Pathways in Human Hepatoma HepG2 and Colon Adenocarcinoma LS174T CellsMarine Drugs, 2012
- Algorithmic and analytical methods in network biologyWIREs Mechanisms of Disease, 2010
- Rifampin, a cytochrome P450 3A inducer, decreases plasma concentrations of antipsychotic risperidone in healthy volunteersJournal of Clinical Pharmacy and Therapeutics, 2007
- The Nuclear Pregnane X Receptor: A Key Regulator of Xenobiotic MetabolismEndocrine Reviews, 2002